Cost-effectiveness of aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy. (Q53207522)
Jump to navigation
Jump to search
scientific article published in January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy. |
scientific article published in January 2007 |
Statements
Cost-effectiveness of aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy. (English)
Susan Moore
John Tumeh
Steven Wojtanowski
Christopher Flowers
1 January 2007
10
1
23-31